Get Started

CLDX

NASD Celldex Therapeutics, Inc.
Oct 31, 2026 · 3:41 AM ET EOD Market Closed

$30.10 ↑ +0.00 (+0.00%) Trading Up from the previous close of $30.10, $0.17 below the day’s high of $30.27

YTD change
+10.82%
vs 20-day SMA
+1.42%
vs 200-day SMA
-7.75%

Price ranges

Previous day
$29.20 $30.27
open $29.70 close $30.10
+$0.40 (+1.35%)
Today
$29.20 $30.27
$30.10
Past week
$28.20 $30.40
from $28.97 now $30.10
+$1.13 (+3.90%)
Past month
$27.47 $32.88
from $32.18 now $30.10
-$2.08 (-6.46%)
This year
$22.33 $45.14
from $27.16 now $30.10
+$2.94 (+10.82%)

Price & Performance

-2.21 (-6.84%) / 6M

$26.14$32.85$39.55$46.26May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 60.0% away from all-time highs of $75.30
  • CLDX is up 11% since the beginning of the year
  • CLDX is up 16% over the past 12 months
  • CLDX is down 6% over the past 1 month
  • 14% of all CLDX investors are betting against CLDX

CLDX reads neutral: price sits above one of the two key moving averages, the 12-month move is +12.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.94
Earnings momentum +7.5% Quarterly EPS growth
Quarterly change +7.5%

Valuation

P/E ratio N/A
Enterprise value $1.6B
Beta 1.47

Balance sheet & scale

IncomeN/A
Revenue$158.0K
Cash$711.3M
Debt$4.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $2.4B

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $466.01 +1.15%
MRNA Moderna, Inc. $221.72 -0.47%
RVMD Revolution Medicines, Inc. $191.31 +0.55%
ROIV Roivant Sciences Ltd. $36.91 -1.63%
BNTX BioNTech SE Sponsored ADR $88.17 -1.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.